Enhanced chalcopyrite-catalyzed heterogeneous Fenton oxidation of diclofenac by ABTS

The widely used 2,2 '-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (ABTS) has gained growing attention in advanced oxidation processes (AOPs), whereas there was limited knowledge regarding the feasibility of ABTS in enhancing heterogeneous Fenton oxidation so far. Hereof, ABTS was introduced into the chalcopyrite (CuFeS2)-catalyzed heterogeneous Fenton oxidation process to degrade diclofenac (DCF), and the degradation efficiency was enhanced by 25.5% compared with CuFeS2/H2O2 process. The available reactive oxygen species (ROS) and the enhanced mechanism were elaborated. Experimental results uncovered that center dot OH was the dominant reactive species responsible for the DCF degradation in the CuFeS2/H2O2/ABTS process, and ABTS center dot+ was derived from both center dot OH and Fe(IV). The presence of ABTS contributed significantly to the redox cycle of surface Fe of CuFeS2, and the roles of reductive sulfur species and surface Cu(I) in promoting surface Fe cycling also could not be neglected. In addition, the effects of several influencing factors were considered, and the potential practicability of this oxidation process was examined. The results demonstrate that the CuFeS2/H2O2/ABTS process would be a promising approach for water purification. This study will contribute to the development of enhancing strategies using ABTS as a redox mediator for heterogeneous Fenton oxidation of pharmaceuticals.